AAAAAA

   
Results: 1-8 |
Results: 8
PREVALENCE OF GBV-C RNA AND ANTI-E2 AMONG INTRAVENOUS-DRUG-USERS AND BLOOD-DONORS IN THE NETHERLANDS
Authors: BOLAND GJ JONGERIUS JM ITALIAANDER E VANDERREIJDEN JJ VANDERPOEL CL VANLEEUWEN EF VANHATTUM J
Citation: Gj. Boland et al., PREVALENCE OF GBV-C RNA AND ANTI-E2 AMONG INTRAVENOUS-DRUG-USERS AND BLOOD-DONORS IN THE NETHERLANDS, Hepatology, 26(4), 1997, pp. 782-782
HLA CLASS-II ALLELES AND THE RESPONSE TO HEPATITIS-B VACCINATION
Authors: BOLAND GJ SCHREUDER GMT ITALIAANDER E VANDERREIJDEN JJ VERDUIN W DUTHLER E VANHATTUM J
Citation: Gj. Boland et al., HLA CLASS-II ALLELES AND THE RESPONSE TO HEPATITIS-B VACCINATION, Hepatology, 26(4), 1997, pp. 1424-1424
PREVALENCE OF GBV-C RNA AMONG SEVERAL POPULATIONS IN THE NETHERLANDS
Authors: JONGERIUS JM BOLAND GJ RASCH MC ITALIAANDER E VANDERREIJDEN JJ VANDERPOEL CL VANLEEUWEN EF VANHATTUM J
Citation: Jm. Jongerius et al., PREVALENCE OF GBV-C RNA AMONG SEVERAL POPULATIONS IN THE NETHERLANDS, Transfusion, 37(9), 1997, pp. 344-344
PREVALENCE OF GBV-C ANTI-E2 AMONG BLOOD-DONORS AND INTRAVENOUS-DRUG-USERS IN THE NETHERLANDS
Authors: JONGERIUS JM BOLAND GJ RASCH MC ITALIAANDER E VANDERREIJDEN JJ VANDERPOEL CL VONLEEUWEN EF VONHATTUM J
Citation: Jm. Jongerius et al., PREVALENCE OF GBV-C ANTI-E2 AMONG BLOOD-DONORS AND INTRAVENOUS-DRUG-USERS IN THE NETHERLANDS, Transfusion, 37(9), 1997, pp. 348-348
FORMATION OF B-CELL IMMUNITY TO HEPATITIS-B INFECTION AFTER A 2-DOSE HEPATITIS-B VACCINATION SCHEDULE
Authors: BOLAND GJ ITALIAANDER E VANDERREIJDEN JJ VANHATTUM J
Citation: Gj. Boland et al., FORMATION OF B-CELL IMMUNITY TO HEPATITIS-B INFECTION AFTER A 2-DOSE HEPATITIS-B VACCINATION SCHEDULE, Gastroenterology, 112(4), 1997, pp. 1229-1229
HEPATITIS-B VACCINATION WITH ADDITION OF G-CSF AS ADJUVANT IN MICE
Authors: BOLAND GJ VANDERREIJDEN JJ ITALIAANDER E VANHATTUM J
Citation: Gj. Boland et al., HEPATITIS-B VACCINATION WITH ADDITION OF G-CSF AS ADJUVANT IN MICE, Hepatology, 24(4), 1996, pp. 641-641
LONG-TERM IMMUNITY TO HEPATITIS-B INFECTION AFTER VACCINATION WITH RECOMBINANT HEPATITIS-B VACCINE
Authors: BOLAND GJ DEGAST GC ITALIAANDER E VANDERREIJDEN J VANHATTUM J
Citation: Gj. Boland et al., LONG-TERM IMMUNITY TO HEPATITIS-B INFECTION AFTER VACCINATION WITH RECOMBINANT HEPATITIS-B VACCINE, Hepatology, 22(4), 1995, pp. 873-873
EXOGENOUS PROTOPORPHYRIN INHIBITS HEP G2 CELL-PROLIFERATION, INCREASES THE INTRACELLULAR HYDROGEN-PEROXIDE CONCENTRATION AND CAUSES ULTRASTRUCTURAL ALTERATIONS
Authors: KONINGSBERGER JC RADEMAKERS LHPM VANHATTUM J DELAFAILLE HB WIEGMAN LJJM ITALIAANDER E HENEGOUWEN GPVB MARX JJM
Citation: Jc. Koningsberger et al., EXOGENOUS PROTOPORPHYRIN INHIBITS HEP G2 CELL-PROLIFERATION, INCREASES THE INTRACELLULAR HYDROGEN-PEROXIDE CONCENTRATION AND CAUSES ULTRASTRUCTURAL ALTERATIONS, Journal of hepatology, 22(1), 1995, pp. 57-65
Risultati: 1-8 |